Superworth

Artelo Biosciences EPS ARTL

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$207.09
Latest quarter, Q2 FY26
−$8.01
Fiscal year 2025
−$427.77

Artelo Biosciences' earnings per share was −$207.09 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$8.01.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$427.77n/a
FY2024−$494.10n/a
FY2023n/an/a
FY2021−$1044.90n/a
FY2020−$3110.40n/a
FY2019−$2843.10n/a
FY2018−$5273.10n/a
FY2017−$388.80n/a
FY2016$0.00n/a
FY2015$0.00n/a
FY2014−$1360.80n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$8.01n/a−$207.09
Q1 FY26−$36.00n/a−$350.82
Q4 FY25−$55.89n/a−$427.77
Q3 FY25−$107.19n/a−$560.88
Q2 FY25−$151.74n/a−$510.39
Q1 FY25−$112.95n/a−$480.69
Q4 FY24−$189.00n/a−$494.10
Q3 FY24−$56.70n/a−$462.24
Q2 FY24−$122.04n/a−$540.00
Q1 FY24−$126.36n/an/a
Q4 FY23−$157.14n/an/a
Q3 FY23−$134.46n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Artelo Biosciences' size, closest first, today.

CompanyEPS, 12 months
ARTLArtelo Biosciences−$207.09
LNAILunai Bioworksn/m
GNPXGenprexn/m
GOVXGeoVax Labsn/m
ONCOOnconetix−$199.38
MTNBMatinas BioPharma−$18.15
PPCBPropanc Biopharma−$26.02
SILOSilo Pharma−$5.41
OGENOragenics−$3.58
KAPAKairos Pharma, LTD.−$1.96
VBIOValion Bion/m
Peer median−$11.78

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Artelo Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.